AXM Pharma, Inc.
AXMP
$0.0001
$0.000.00%
OTC PK
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | 31.03M | 31.03M | 24.31M | 24.31M | 32.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.03M | 31.03M | 24.31M | 24.31M | 32.23M |
| Cost of Revenue | 26.35M | 26.35M | 18.60M | 18.60M | 27.90M |
| Gross Profit | 4.67M | 4.67M | 5.71M | 5.71M | 4.33M |
| SG&A Expenses | 1.42M | 1.42M | 2.65M | 2.65M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 215.20K | 215.20K | -124.70K | -124.70K | 464.30K |
| Total Operating Expenses | 27.99M | 27.99M | 21.12M | 21.12M | 28.36M |
| Operating Income | 3.04M | 3.04M | 3.19M | 3.19M | 3.86M |
| Income Before Tax | 2.37M | 2.37M | 3.59M | 3.59M | 2.52M |
| Income Tax Expenses | 429.00K | 429.00K | 1.35M | 1.35M | 664.90K |
| Earnings from Continuing Operations | 1.94M | 1.94M | 2.24M | 2.24M | 1.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.94M | 1.94M | 2.24M | 2.24M | 1.85M |
| EBIT | 3.04M | 3.04M | 3.19M | 3.19M | 3.86M |
| EBITDA | 3.29M | 3.29M | 3.48M | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Average Basic Shares Outstanding | 5.30B | 5.30B | 5.30B | 5.30B | -- |
| Average Diluted Shares Outstanding | 5.30B | 5.30B | 5.30B | 5.30B | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |